Physician profile
Joseph Johnson
NPI 1609858372
$3,591.90
in general payments reported to CMS, 2019-2025
31 companies · $1,565 in 2025
The $1,565 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $24.52 · 2021: $205 · 2022: $340 · 2023: $417 · 2024: $933 · 2025: $1,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,914.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $722.62 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $462.60 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $332.15 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $275.54 | 2021-2025 | |
| Glaxosmithkline, LLC. | $254.75 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $147.42 | 2019-2025 | Kisunla, Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.21 | 2022-2025 | Xifaxan |
| Stryker Corporation | $122.31 | 2025 | T2 Alpha |
| Boston Scientific Corporation | $100.60 | 2023-2024 | Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $100.42 | 2019-2025 | Krystexxa |
| Dexcom, INC. | $90.77 | 2024-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $86.65 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.88 | 2024-2025 | |
| Exact Sciences Corporation | $79.36 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $76.33 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $67.02 | 2024-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.95 | 2022-2025 | Ofev |
| Amarin Pharma, INC. | $47.60 | 2019-2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $44.23 | 2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $38.08 | 2025 | Rexulti |
| Eisai INC. | $35.99 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $35.49 | 2023-2024 | Eliquis |
| Astellas Pharma US INC | $30.75 | 2024 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $28.68 | 2025 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $27.84 | 2021-2023 | Seglentis, Livalo |
| Sanofi-Aventis U.S. LLC | $23.75 | 2025 | |
| Shield Therapeutics INC | $19.93 | 2024 | |
| Sumitomo Pharma America, INC. | $18.15 | 2024 | Gemtesa |
| Corcept Therapeutics | $15.48 | 2019 | |
| Phathom Pharmaceuticals, INC. | $14.41 | 2024 | Voquezna |
| Musculoskeletal Transplant Foundation INC. | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.